← Leaderboards
Mary F. Morrison
Temple Univ Of The Commonwealth
$5,117,685
Attributed
$5,117,685
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2020–23$2M$1.5M$1M$500K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$5,117,685 · 1
By mechanism
U01$5,117,685 · 1
Top collaborators
No co-investigators on record.
Most similar at Temple Univ Of The Commonwealth
Same institution · by research overlap
- Scott M Rawls$11,077,907
- Lisa A Briand$3,976,692
- Magid Abou-Gharbia$1,840,619
- Charlotte Chloe Bavley$66,390
Others in their field
Other Emerging Leaders on “Addiction”
- Eve Jelstrom · The Emmes Company, Llc$35,258,152
- Jeffrey Reich · Sparian Biosciences, Inc.$17,713,936
- Emmanuel Aja Oga · Research Triangle Institute$17,220,162
- Suparna Goswami · Univ Of North Carolina Chapel Hill$16,919,767
- Mark Brian Reed · San Diego State University$13,246,314
- Nikej Shah · Nirsum Laboratories, Inc.$12,506,430
Research focus
AddictionAdultAlcohol Preferring RatsAmoxicillin-Potassium Clavulanate CombinationAnimalsAnteriorAntibioticsAreaBackBehaviorBehavior TherapyBenzoylecgonineBeta-LactamsBiological MarkersBrainBrain RegionCause Of DeathCensusesCessation Of LifeChronicCingulate CortexClavulanic AcidsClinical DevelopmentAbstinence
Grant awards (3)
Drug development of clavulanic acid, a GLT-1 activator: proof of concept for cocaine use disorder$1,388,259
U01 · FY2023 · DA · contact PI
Drug development of clavulanic acid, a GLT-1 activator: proof of concept for cocaine use disorder$1,951,956
U01 · FY2022 · DA · contact PI
Drug development of clavulanic acid, a GLT-1 activator: proof of concept for cocaine use disorder$1,777,470
U01 · FY2020 · DA · contact PI